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Protein dynamicsThe insulin receptor (IR) binds insulin and plays important roles in glucose homeostasis by regulating the tyro-
sine kinase activity at its C-terminus. Its transmembrane domain (TMD) is shown to be important for transferring
conformational changes induced by insulin across the cell membrane to regulate kinase activity. In this study, a
construct IR940–988 containing the TMDwas expressed and puriﬁed for structural studies. Its solution structure in
dodecylphosphocholine (DPC) micelles was determined. The sequence containing residues L962 to Y976 of the
TMD of the IR in micelles adopts a well-deﬁned helical structure with a kink formed by glycine and proline res-
idues present at its N-terminus,whichmight be important for its function. Paramagnetic relaxation enhancement
(PRE) and relaxation experimental results suggest that residues following the TMD are ﬂexible and expose to
aqueous solution. Although puriﬁed IR940–988 in micelles existed mainly as a monomeric form veriﬁed by gel
ﬁltration and relaxation analysis, cross-linking study suggests that it may form a dimer or oligomers under
micelle conditions.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The insulin receptor (IR) belongs to receptor tyrosine kinase (RTK)
family that contains single-pass transmembrane proteins and com-
prises 59 members in human [1,2]. RTK family protein interacts with
its ligand to play critical roles in cellular signaling through regulating
its kinase activity that phosphorylates speciﬁc tyrosine residues on
other signaling proteins or itself [1,2]. The IR plays a critical role in reg-
ulation of glucose homeostasis through interacting with insulin [1,3].
Unlike other RTKs, the IR is a heterodimeric disulﬁde-linked protein
composed of twoα-subunits and β-subunits in the absence of its ligand
[3]. Both α- and β-subunits are resulting from the cleavage of a same
proreceptor. The IR is encoded by its gene and transcripted into IR-A
and B isoforms with 12 amino acids difference in the α-subunit [3].
The α-subunits are located outside of the cell membrane and contain
two leucine-rich repeats (L1 and L2), a cysteine rich region (CR), and
two ﬁbronectin type III domains (FnIII1-2) [3,4]. The FnIII-2 contains a
120 amino acids insert (ID) with a protease cleavage site to generate
the α and β subunits [1]. The β-subunits contain two FnIIIs, a trans-
membrane domain (TMD) and a tyrosine kinase catalytic domain that
can be activated through ligand binding to the α subunits [4].
The effect of insulin on the structure of its receptor has been studied
for many years. The possible mechanism of insulin induced receptor
activation is that insulin binding to the IR induces conformationals, #03-01, Singapore 138669,
ights reserved.changes that can be transmitted to the cytoplasmic domain to facilitate
its phosphorylation. Phosphorylation on tyrosine residues in the
cytoplasmic domains creates docking sites for molecular interaction
with downstream signaling proteins or stimulates its catalytic activity
[5,6]. Structural studies have been conducted for the domains of the IR
using different techniques including X-ray crystallography, NMR spec-
troscopy and dark-ﬁeld scanning transmission electron microscopy
[4,7,8]. Although structural study of the IR ectodomain is challenging
due to its large size, ﬂexibility, glycosylation and existence of disulphide
bonds, structural studies have shown the structural basis for its interac-
tion with insulin [4,7,9–12]. Structural basis for the two surfaces of
insulin interacting with the IR domains has been provided by several
studies [10,13,14]. It is evident that insulin binding to its receptor causes
structural changes, but the precise effect of the conformational changes
on the kinase domain still remains unresolved [6].
The TMD of the insulin receptor is within theβ-subunit and contains
23 amino acids [15]. Earlier studies suggested that modiﬁcation in the
TMD could alter receptor internalization and insulin signaling [16,17].
Mutations in the TMD were shown to have effects on receptor biosyn-
thetic processing and kinase activation [18]. Substitution of the entire
TMD of the IR with the TMD of c-neu/erbB2 resulted in constitutive
kinase activation in vitro, while replacing the TMD with that of
glycophorin A inhibited insulin action [15]. Although the TMD of IR
does not interact with insulin directly, studies have suggested that the
TM–TM interactions may affect the activation of the kinase domain of
the receptor [15].
The structure of the TMD of the IR was predicted to be an α-helix.
There is no structure of this domain that has been reported so far. In
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conducted structural studies in detergent micelles using NMR spectros-
copy. Our results show that the TMD contains a helix and a kink when it
is puriﬁed in DPC micelles. The residues 942–948 preceding the TMD
have a propensity to be a short helix and may interact with membrane.
Our cross-linking study suggested that itmay form a dimer or oligomers
under micelle conditions.
2. Materials and methods
2.1. Materials
The DNA polymerase, restriction enzyme for molecular cloning
was purchased from New England Biolabs. The pET-29b plasmids
were purchased from Merck. The SDS-PAGE system, NuPAGE® gels,
DH5α competent cells and SDS-PAGE molecular weight standard were
purchased from Invitrogen and Bio-rad. The Bl21 (DE3) competent
cells for protein expression were purchased from StrataGen. β-D-1-
thiogalactopyranoside (IPTG) and dithiothreitol (DTT) and detergents
were purchased from Anatrace or Avanti. The 15NH4Cl, 13C-glucose
and D2O were purchased from Cambridge Isotope. All other chemicals
were purchased from Sigma.
2.2. Expression and puriﬁcation of TMD of IR
The cDNA encoding residues Thr940 to Leu988 (IR940–988) of human
IR were synthesized (Genscript). Sequence number is based on the
sequence from the protein knowledgebase (www.uniprot.org) with
access number P06213. The cDNA was cloned into the NdeI and XhoI
sites of pET29b to generate a plasmid-pET29-IRTM encoding a protein
sequence with extra residues (EHHHHHH) at its C-terminus to aid pro-
tein puriﬁcation. The resulting plasmid was transformed in Escherichia
coli (E. coli) competent cells and plated onto LB plates containing kana-
mycin. Two to three colonies were picked up and inoculated in 10ml of
M9medium and cultured at 37 °C overnight. The overnight culture was
then inoculated into 1 l M9 medium with antibiotics. When OD600
reaches 0.6–1.0, protein was induced for 12 h at 37 °C by adding IPTG
to 1 mM. Isotope-labeled proteins were also induced using the similar
method except using labeled carbon and nitrogen sources [19]. The
E. coli cells were harvested by centrifuging at 11,000 ×g for 10 min at
4 °C, and the cell pellets were re-suspended into a lysis buffer (20 mM
Tris-HCl, pH 7.8, 300 mM NaCl, and 2 mM β-mercaptoethanol) and
were then broken up by sonication on ice. The cell lysate was cleared
by centrifugation at 20,000 ×g for 20 min. The pellet was washed with
the lysis buffer one time and collected with centrifugation to obtain
inclusion bodies. Inclusion bodies were solubilized in a urea buffer
(8M urea, 300mMNaCl, 7 mM SDS, 20mM Tris-HCl, pH7.8) by rotating
at room temperature for 2–10h [20,21]. The solutionwas then cleared by
centrifugation at 48,000 ×g for 20 min at room temperature. The super-
natantwas loaded in a gravity column containing nitrilotriacetic acid sat-
uratedwith nickel (Ni2+-NTA) resin. Next, the resinwaswashedwith 10
columnvolumes of urea buffer. Ureawas then removed bywashing resin
with 10 column volumes of lysis buffer with 7 mM SDS and 20 mM im-
idazole. Protein was eluted with an elution buffer (300 mM imidazole,
pH6.5, 2–20mMdetergent) afterwashing resinwith 10 columnvolumes
of washing buffer (lysis buffer with 2–20 mM detergent). To prepare an
NMR sample that is selectively labeledwith a 15N-labeled amino acid, the
Bl21 (DE3) E. coli cells were ﬁrst inoculated into a M9 medium that
contained 0.5 g/l NH4Cl. When IPTG was added into the medium to in-
duce the protein, the 15N-labeled amino (0.1 g/L) and 19 unlabeled
amino acids (0.1 g/l) were added at the same time [19]. Protein was
then puriﬁed as aforementioned for acquiring a 1H-15N-HSQC spectrum.
To prepare anNMR sample, imidazolewas removed by using a PD10 col-
umn or gel ﬁltration chromatography. Sample was concentrated and put
into an NMR tube for data acquisition.2.3. Gel ﬁltration experiment
Puriﬁed protein using Ni2+-NTA resin was concentrated and
loaded on a superdex™ 200 10/300 GL column that was pre-
equilibrated with a gel ﬁltration buffer (20 mM sodium phosphate,
8 mM dodecylphosphocholine (DPC) and 1 mM DTT). The ﬂow rate
was 0.5 ml/min and experiment was conducted at room temperature.
The absorbance at 280 nm was monitored continuously and fractions
were collected for analysis.
2.4. NMR experiments
NMR samples (0.3mM)were prepared in 20mMsodiumphosphate
buffer, pH 6.5, 1 mM DTT and (100–200 mM) detergent. All NMR
spectra were recorded at 313 K on Bruker Avance 600 and Avance 700
spectrometers with cryogenic triple resonance probes [22]. All the
pulse programswere fromTopspin 2.1 program library. Datawere proc-
essed with NMRPipe [23] and analyzed using NMRView [24]. Backbone
resonances assignment was obtained using 2D-1H-15N-HSQC, 3D
HNCACB, HNCA, HN(CO)CA, HN(CO)CACB, HNCO and HBHACONH
experiments. Secondary structure was identiﬁed by analysis of 13C
secondary chemical shift [25] and TALOS+[26]. Distance constraints
were collected from a 3D 15N-edited NOESY (mixing time = 100 ms)
experiment using a 13C and 15N-labeled sample under aforementioned
conditions. Paramagnetic relaxation enhancement (PRE) experiment
was conducted using 15N-labeled samples. IR940–988 was prepared at
0.3 mM concentration in the buffer containing 20 mM sodium phos-
phate, pH6.5, 1 mM DTT, and 120 mM DPC. The 16-doxyl stearic acid
(16DSA)was dissolved in d4-methanol tomake a 50mMstock solution.
The 1H-15N-HSQC spectra of IR940–988 in the absence andpresence of dif-
ferent concentrations of 16DSA were collected. The peak intensities
were obtained using NMRview [24]. The ratio of peak intensities before
and after adding 16DSA was plotted against residue number.
2.5. Structure determination
The backbone dihedral angle restraints were generated using
TALOS+[26]. The NOEs peaks were picked manually and calibrated
using NMRview [24]. The nuclear Overhauser effect (NOEs) peak inten-
sity was converted to distance restraints. H–D exchange experiment
was conducted by adding D2O into lyophilized IR in DPC micelles.
1H-15N-HSQC was recorded immediately when the sample was dis-
solved in D2O. The peaks appeared in the HSQC spectrum were used
as hydrogen bond restraints. The upper and lower distances used in hy-
drogen bond restraintswere 2.8 and 1.8 Å, respectively. Structure deter-
mination was carried out using XPLORE-NIH [27–29]. Structure
determinationwas carried out using a randomized template. Simulated
annealing was performed and energy minimization was carried out as
previously described [30]. Simulated annealing was carried out with
starting temperature of 3000 K and 50, 000 cooling steps. The structure
was energy-minimized with 250 steps of Powell energy minimization.
Fifty structureswere obtained and twenty of themwith lowest energies
were selected and deposited in protein data bank with access number
2MFR.
2.6. Relaxation analysis
T1, T2 and {1H}-15N steady-state NOE experiments [31] were mea-
sured at 313 K using a 15N-labeled sample on a Bruker Avance II
600 MHz spectrometer. For T1 measurement, the relaxation delays of
5, 40, 80, 130, 330, 470, 630, 800, 900, 1000, 1200, 1400, 1600 and
1800 ms were recorded. For T2 measurement, the data were acquired
with delays of 16.9, 34, 51, 68, 85, 102, 119, 136 and 153 ms. Steady-
state {1H}-15N NOEs were obtained using two datasets that were col-
lected with and without initial proton saturation for a period of 3 s [32].
1315Q. Li et al. / Biochimica et Biophysica Acta 1838 (2014) 1313–13212.7. Cross-linking experiment
Cross-linking of IR940–988 by glutaraldehydewas carried out to test if
the puriﬁed protein could form a dimer or oligomers in DPC micelles.
Themethodwas same as described [33]with some changes in thebuffer
conditions. Puriﬁed samples from E. coliwere buffer-exchanged to the
cross-linking buffer that contained 20 mM Sodium phosphate, pH6.5,
14 mM DPC and 0.1 mM DTT. Protein concentration was diluted to
25 μM to a ﬁnal volume of 50 μl. Glutaraldehyde (GA) from a 25%
stock was added to 16 mM. Mixture was kept at room temperature for
10minwith rotation. Sampleswith andwithout cross-linkingwere sep-
arated by SDS-PAGE and protein bands were visualized by Coomassie
staining and Western blot using an anti-his antibody.3. Results
3.1. NMR spectra of IR940–988 in detergent micelles
To understand the structure of the TMD of the IR, we expressed and
puriﬁed a construct that encompasses residues 940 to 988 (IR940–988).
IR940–988 was expressed into inclusion bodies and puriﬁed by on-
column refolding into different detergent micelles that are necessary
for the folding of the TMD. Protein was further puriﬁed by gel ﬁltration
chromatography (Fig. 2). Detergentmicelles have beenused for structur-
al study ofmembrane proteins due to its similarity to cell membrane and
small size [34,35]. It is still difﬁcult to decide which detergent is suitable
for structural studies without experimental evidence. To select a suitable
detergent for structural study, we tested four detergents including
Sodium dodecyl sulfate (SDS), DPC, lauryldimethyl amine oxide
(LDAO) and lyso-myristoyl phosphatidylglycerol (LMPG) because they
were commonly used in membrane protein structural studies by NMR
[36–38]. The yield of IR940–988 was observed to be similar when these
four detergents were used in puriﬁcation. We could obtain about
0.3 mg of 13C/15N-labeled protein from 1 l culture. The effect of different
detergents on the 1H-15N-HSQC spectra was compared (Fig. 3). Puriﬁed
IR940–988 exhibited dispersed cross-peaks in the 1H-15N-HSQC spectra
when it was reconstituted into these detergent micelles (Fig. 3). When
the construct was reconstituted in LMPG micelles, the 1H-15N-HSQC
spectrum showed some broaden peaks, which may arise from the fact
that the sample as not homogenous or the presence of multipleFig. 1. Insulin receptor and the construct used in this study. A. Insulin receptor diagram. L1, L
domains 1–3; RTK, receptor tyrosin kinase domain; TM, transmembranedomain; ID, insert dom
is based on the sequence from the protein knowledgebase (www.uniprot.org) with access numconformations and oligomers when it was puriﬁed in LMPG. Among
these four detergents, we ﬁnally choose DPC micelles for further
structural studies because the number of the cross-peaks in the HSQC
spectrum agrees well with the residue number of the construct used in
this study.
3.2. Secondary structure of IR940–988
The resonance assignment of IR940–988 inDPCmicelleswas conducted
using conventional 3D experiments. Ambiguities in the assignmentwere
cleared using amino-acid speciﬁc labeled samples including 15N-labeled
Arg, Phe and Ile. Nearly complete backbone resonances including H(N),
N, CO, Cα and Hα and partial side chain resonances including Cβ and
Hβ were obtained and the chemical shifts have been deposited in the
BioMagResBank (BMRB) with access number 19568. The assignment of
1H-15N-HSQC spectrum is shown in Fig. 4A. Chemical shift analysis
using Cα chemical shifts and TALOS+ analysis showed that the trans-
membrane region of the IR is mainly α-helical with a break present
(Fig. 4). TALOS+ analysis indicated that the break occurs at Gly960. It
is not surprising to observe such a kink structure present in the TMD
due to the presence of Pro961 (Fig. 4). The C-terminus of IR940–988 is
disordered. TALOS+ and NOE connection analysis shows that there is
one short sequence (residues 942–946) that precedes the TMD had a
propensity to form a short helix (Fig. 4).
3.3. Solution structure of IR940–988
The solution structure of IR940–988 in DPC micelles at 313 K was
determined using restraints that contained dihedral angles derived
from TALOS+ and short-range NOEs using Xplor-NIH. The TMD of the
IR contains a well-deﬁned α-helix (residues 962 to 976) with a kink
containing Gly960 and Pro961 as observed in the secondary structure
analysis. The C-terminus region (residues 983–988) following the
TMD is ﬂexible. The ensemble of twenty structures of IR940–988 with
lowest energies is shown in Fig. 5. Table 1 shows the statistics of the de-
termined IR940–988 structure. The pair wise rootmean squared deviation
(rmsd) of the TMD was 0.55 Å for backbone atoms and 1.12 Å for the
heavy atoms. As there is no long-rangeNOE included in structural deter-
mination, the orientation of the sequence preceding the TMD was not
deﬁned. Surface charge representation of IR940–988 showed that TMD2, ﬁrst and second leucine rich repeat; CR, Cys rich domain; FnIII-1-3, ﬁbronectin type III
ain; C-tail, region after theRKT. B. IR940–988 sequence andpredicted TMD. Sequencenumber
ber P06213.
Fig. 2. Puriﬁcation of IR940–988 from E. coli. A. Gel ﬁltration proﬁle of IR940–988 in DPC micelles. B. SDS-PAGE gel analysis of the puriﬁed sample. Protein was expressed and puriﬁed as
described in Materials and method. 1. Protein molecular weight standard. 2. Puriﬁed IR940–988. Arrow indicates IR940–988.
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region because it contains mainly hydrophobic residues. The residues
following the TMD form a positively charged surface which arises
from the presence of the charged residues such as Arg (Fig. 1 and 5).
The amino acid sequence (residues 942–948) preceding the TMD have
a tendency to be a helix based on the TALOS+ analysis and the model
shows a hydrophobic surface (Fig. 5). Most of the residues forming
this helix are hydrophobic (Fig. 5E), suggesting that this modeledFig. 3. 2D 1H-15N-HSQC spectra of puriﬁed IR940–988 in different detergentmicelles. All the spectr
SDS (A), 280 mM DPC (B), 200 mM LDAO (C) and 100 mM LMPG (D).helix may interact with micelles as shown in the model (Fig. 6A).
There was no water proton and amide proton NOEs observed for
these residues of the region except that residues Thr945 and
Asp946 show weak NOEs with water (Fig. 6B). To further probe if
the N-terminal amino acids of the TMD interact with micelles, we car-
ried out PRE experiment using 16DSA. If a residue is buried in a micelle
or interactswith amicelle, peak intensitywill be affectedwhen 16DSA is
added [39]. The most affected residues are those compassing residuesawere acquired at 40 °C. Puriﬁed protein (0.3mM) is in the following detergents: 140mM
Fig. 4. Assignment of IR940–988 in DPC micelles. A. Assignment of the 1H-15N-HSQC spectrum of IR940–988 in DPC micelles. B. Amino acid sequence for IR940–988 used in the study. The
histidine tag was not shown for clarity. C. Secondary structure analysis using TALOS+. The result was obtained from TALOS+ analysis [26]. Positive values indicate the possibility
(from0 to 1) to be helical structures, while negative values indicate the possibility to beβ-sheets. D. Secondary structure prediction using Cα chemical shifts. The chemical shift differences
(ΔCα) between Cα chemical shifts and the random coil values as a function of residue numbers are plotted. Positive value of an amino acid suggests that this residue is helical. E. NOE
connections of IR940–988 in DPC micelles.
1317Q. Li et al. / Biochimica et Biophysica Acta 1838 (2014) 1313–1321Ile958 to Leu979 that form the TMD of the IR. Some residues from the
N-terminal helix are also affected by 16DSA, suggesting that they are
buried in or interact with micelles (Fig. 6C). The peak intensities of
the residues from the C-terminus and the loop show no signiﬁcant
changes, suggesting that these residues are exposed to the aqueous
solution (Fig. 6C). The PRE result and the NOE analysis suggest that
the N-terminal amino acid sequence (942–945) is interacting with
DPC micelles, which demonstrates that it may interact with cell
membrane in vivo.
3.4. Relaxation analysis
The 15N T1, T2 and steady-state 1H-15N NOE parameters were mea-
sured and analyzed, which is shown in Fig. 7. The N- and C-terminus
of IR940–988 are ﬂexible, characterized by low T1, NOE values and higher
T2 values (Fig. 7). The N-terminal region of IR940–988 and the TMD of the
IR showed different average T1, T2 and NOEs, indicating that these tworegions existed in different environment. For the TMD, the average T1
and T2 values are 0.95 s and 54.2 ms, respectively. For the amino acids
(942–948) preceding the TMD, the average T1 and T2 values are 0.66 s
and 96 ms, respectively. The result suggests that this N-terminal
sequence is not completely buried in the micelles. From the T1/T2 ratio
plateau of the TMD, the overall correlation time for the TMD-DPC mi-
celle complex is roughly 13.0 ns, which is consistent with a protein–
DPC micelles aggregate molecular mass in the range of 20–25 kDa.
From the relaxation analysis, the residues from Ile957 to Leu980 are
buried in the DPC micelles because they have higher T1 values than
that of the average value of the IR940–988.
3.5. Cross-linking study
The dynamic studies suggested that IR940–988 existed as a monomer
in DPCmicelles. The oligomeric state of IR940–988 was examined when it
was diluted in DPC micelles. Chemical cross-linking was carried out
Fig. 5. Structure of IR940–988 in DPCmicelles. A and B. Superimposed 20 structureswith lowest energies. Structures with side chains (A) and only backbone atoms (B) are shown. C. Ribbon
representation for the lowest-energy conformer of IR940–988. The C-terminal histidine tag is not shown for clarity. Gly and proline residues are shown in sticks. D. Color-coded electrostatic
surface potential for the IR940–988. All the ﬁgures are generated using PyMOL (www.pymol.org). Positive and negative potential are shown in blue and red, respectively. E. Model of the
sequence preceding the TMD. The N-terminal sequence was predicted to be a short helix based on dihedral angles derived from TALOS+. The hydrophobic residues are shown in sticks.
Upper panel is the cartoon representation of the helix. Middle and bottom panels are color-coded electrostatic surface potential analysis for this helix.
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a dimer band appeared when GA was present, suggesting that this con-
struct could form a dimer under micelle conditions (Fig. 8A). Western
blot analysis using an anti-his antibody shows that there are multi-
bands present when GA was added into the protein solution, but the
dominant monomer was still present (Fig. 8B). Even after overnight
cross-linking with GA, the IR monomer band was still prominent
(data not shown). This result suggests that IR940–988 could form dimers
or trimers under micelle conditions with low afﬁnities.
4. Discussion
In this study, we puriﬁed IR940–988 of the insulin receptor into DPC
micelles and determined its structure using NMR spectroscopy. There
is a proline residue present in the TMD and our structural studies sug-
gest that there is a kink presentwhen IR940–988 was prepared in DPCmi-
celles. Single-passmembrane proteinswith kinked structures present in
their TMDs have been observed for several proteins such as KCNE1-a
regulator of voltage-gated potassium channels [21] and ost4-a subunit
of oligosaccharyltransferase [40,41]. Previous study suggested that
vertical motions of the TMD of the IR may not occur during insulin-stimulated signaling [18]. It is possible that under certain conditions ro-
tation of the TMD helix is a mechanism to transfer the conformational
changes caused by insulin binding to the cytoplasmic domain to the
kinase domain because rotation of the C-terminal end of the TMD
can bring kinase domains in a close contact. The presence of a kink
in the TMD might provide the ﬂexibility to alter the orientation of the
C-terminal part when insulin binds the IR.
The construct IR940–988 used in current study existed mainly as a
monomer. As shown in Fig. 2A, the majority of the puriﬁed protein
had a retention volume of 15 ml, corresponding to a water soluble pro-
tein with a molecular weight of 30 kDa. Although we could not use
water soluble molecular weight standard to determine the molecular
weight of a membrane protein in micelles using gel ﬁltration chroma-
tography, the retention volume of the current construct inmicelles sug-
gested that the protein/micelle complex behaves like a large molecular
weight protein, which may arise from the presence of detergent mi-
celles. The gel ﬁltration result at least suggests that we are using a ho-
mogenous sample in current studies. In the 1H-15N-HSQC spectrum,
IR940–988 in DPC micelles exhibited nicely dispersed cross-peaks with
narrow line widths, suggesting that the construct exists as a monomer
(Fig. 3). Further relaxation data show that protein/micelle complex
Table 1
Summary of the 20 structures of IR940–988 in DPC micelles.
Number of unambiguous NOEs
Intraresidual (|i− j| = 0) 24
Short range (|i− j| ≤ 1) 85
Medium-range (2 ≤ |i− j| b 5) 22
Long-range (|i− j| N 5) 0
Number of dihedral angle constraints 86
Number of hydrogen-bond restraints 32
Number of restraint violationsa
Total number of restraint violations N 0.5 Å 0
Total number of dihedral angle constraints N 5° 0
Ramachandran plot statisticsb (%)
Residues in most favored regions 92.7
Residues in additionally allowed regions 7.3
Residues in generously allowed regions 0
Residues in disallowed regions 0
Average RMSD to mean (Å)
Backbone (residues 953–981) 0.55 ± 0.15 Å
Heavy atoms (residues 953–981) 1.12 ± 0.20 Å
a There are no distance violations greater than 0.5 Å or dihedral angle violations greater
than 5°. All residues are included in the ﬁnal ensemble.
b The Ramachandran plot analysis does not include residues (LEHHHHH) at the
C-terminus.
Fig. 6.Model of IR940–988 in DPC micelles. A. Model of IR940–988. The structure model of IR940–98
sphere. B. NOEanalysis. TheNOEs for some residues from the residues preceding the TMDwere p
with a dashed line. C. PRE effect of 16DSA on IR940–988 in DPCmicelles. The relative intensity(I(0
1 mM 16DSA (I(p)) is plotted against residue number.
1319Q. Li et al. / Biochimica et Biophysica Acta 1838 (2014) 1313–1321mayhave amolecularweight of 20 kDa corresponding to that of IR940–988
peptide and DPCmicelles, supporting the conclusion that IR940–988 exists
as a monomer under current experimental conditions. Previous studies
showed that the TMDof the IRmay formdimer or oligomer under differ-
ent condition [15–18]. To test if puriﬁed TMD of the IR can form a dimer
under micelle conditions, we carried out a GA cross-linking study. Our
result demonstrated that the TMD could form a dimer or oligomers,
but its binding afﬁnity may be weak (Fig. 8). The reason that we did
not obtain a dimer in our current study may be that the ratio between
detergent and protein is high, which may affect the formation of TM di-
merswhen the afﬁnity of the TM–TM interaction is low [42]. The appear-
ance of oligomeric band suggested that TMDmay have different TM–TM
interfaces. In a previous study, replacing the TMD of IR with that of
glycophorin A inhibited insulin action [15]. Structural study suggested
that TMD of glycophorin A can form strong right-handed dimers
even in the presence of SDS micelles [43]. Replacing the TMD with that
of c-neu/erbB2 resulted in constitutive kinase activation [18]. The solu-
tion structure of the TMD of erbB2 was determined and this domain
can form a homo or a hetero dimer with erbB1 under micelle or bicelle
conditions [44,45]. The mutagenesis study suggested that the TMD of
the IR may form a dimer during insulin signaling. The functional IR
TM–TM interaction needs to be weak because the replacing TMD with
that of glycophorin A inhibited signaling. There is one SXXXG sequence8 in DPC micelles was made based on its solution structure. The DPC micelle is drawn as a
lotted froma3DHSQC-NOESYexperiment. The cross peak fromwater protons is indicated
)/I(p)) of the cross-peaks in the 1H-15N-HSQC spectra in the absence (I(0)) and presence of
Fig. 7. NMR relaxation parameters for IR940–988 in DPC micelles. All the experiments were
recorded at 40 °C. A. T1 (A), T2 (B) and {1H}-15N (C) values of the IR940940–988 are shown.
1320 Q. Li et al. / Biochimica et Biophysica Acta 1838 (2014) 1313–1321present in the TMDof the IR. This sequencemayhave the function as that
of the GXXXGmotif that is commonly used in TM–TM packing [46]. This
motif might be important for the IR TMD dimerization.
In summary, we puriﬁed IR940–988 containing the TMD of the IR
and reconstituted into DPC micelles. The monomer structure of this
construct was determined using NMR spectroscopy. Relaxation and
gel ﬁltration chromatography study suggested that the construct exists
as a monomer under our experimental conditions. The TMD contains a
well-deﬁned helix containing residues 962 to 975. The TMD contains a
kink formed by Gly960 and Pro961, which might be important for its
function.Fig. 8. GA cross-linking of IR940–988 in DPC micelles. A. SDS-PAGE of IR940–988 before and
after cross-linking with GA. B. Western blot analysis of IR940–988 before and after cross-
linking. The proteinwas puriﬁed inDPCmicelles andmixedwith GA. The sampleswithout
andwith GA cross-linkingwere analyzed by SDS-PAGE followed byWestern blot using an
anti-his antibody. The protein bands corresponding to IR940–988 are indicatedwith arrows.Acknowledgements
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